Nutrition impacts the prevalence of peripheral arterial disease in the United States

Journal of Vascular Surgery

Volumn 48, Issue 4, 2008, Pages

  Lane, John S ^a,b   Magno, Cheryl P ^a,b   Lane, Karen T ^a,b   Chan, Tyler ^b   Hoyt, David B ^a   Greenfield, Sheldon ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; PYRIDOXINE; RETINOL; SATURATED FATTY ACID;

AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; FIBER; FOOD COMPOSITION; FOOD INTAKE; GENDER; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERTENSION; LABORATORY TEST; LEG; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NUTRIENT; NUTRIENT CONTENT; NUTRITION EDUCATION; NUTRITIONAL ASSESSMENT; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES; VITAMIN SUPPLEMENTATION;

EID: 55149117086     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.05.014     Document Type: Article

References (31)

1. Hankey G.J., Norman P.E., and Eikelboom J.W. Medical treatment of peripheral arterial disease. JAMA 295 (2006) 547-553
2. McDermott M.M., Mehta S., Ahn H., and Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12 (1997) 209-215
3. World Health Organization. Part 2: Recommendations for Prevention of Cardiovascular Disease. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management for Cardiovascular Risk (2007), WHO Press, Geneva Switzerland. http://www.who.int/cardiovascular_diseases/guidelines/Full%20text.pdf http://www.who.int/cardiovascular_diseases/guidelines/Full%20text.pdf
4. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey Data (NHANES). Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 1999-2004. http://www.cdc.gov/nchs/nhanes.htm.
5. Sacks D., Bakal C.W., Beatty P.T., Becker G.J., Cardella J.F., Raabe R.D., et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular & interventional radiology. J Vasc Interv Radiol 13 (2002) 353
6. U.S. Department of Health and Human Services. U.S. Department of Agriculture. Dietary Guidelines for Americans (2005), US Department of Health and Human Services, Rockville, MD
7. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes (DRI): Recommended Intakes for Individuals (2004), National Academies Press, Washington, DC
8. Karvetti R.L., and Knuts L.R. Validity of the 24-hour dietary recall. J Am Diet Assoc 85 (1985) 1437-1442
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
10. Carrero J.J., and Grimble R.F. Does nutrition have a role in peripheral vascular disease?. Br J Nutr 95 (2006) 217-229
11. Mead A., Atkinson G., Albin D., Alphey D., Baic S., Boyd O., et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet 19 (2006) 401-419
12. Spark J.I., Robinson J.M., Gallavin L., Gough M.J., Homer-Vanniasinkam S., Kester R.C., et al. Patients with chronic critical limb ischaemia have reduced total antioxidant capacity and impaired nutritional status. Eur J Vasc Endovasc Surg 24 (2002) 535-539
13. Donnan P.T., Thomson M., Fowkes F.G., Prescott R.J., and Housley E. Diet as a risk factor for peripheral arterial disease in the general population: the Edinburgh Artery Study. Am J Clin Nutr 57 (1993) 917-921
14. Langlois M., Duprez D., Delanghe J., De Buyzere M., and Clement D.L. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103 (2001) 1863-1868
15. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., and Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 392 (1998) 559
16. Klipstein-Grobusch K., den Breeijen J.H., Grobbee D.E., Boeing H., Hofman A., and Witteman J.C. Dietary antioxidants and peripheral arterial disease: the Rotterdam Study. Am J Epidemiol 154 (2001) 145-149
17. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293 (2005) 1338-1347
18. Kuan Y.M., Dear A.E., and Grigg M.J. Homocysteine: an aetiological contributor to peripheral vascular arterial disease. ANZ J Surg 72 (2002) 668-671
19. Ciccarone E., Di Castelnuovo A., Assanelli D., Archetti S., Ruggeri G., Salcuni N., et al. Homocysteine levels are associated with the severity of peripheral arterial disease in type 2 diabetic patients. J Thromb Haemost 1 (2003) 2540-2547
20. van den Berg M., Franken D.G., Boers G.H., Blom H.J., Jakobs C., Stehouwer C.D., et al. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg 20 (1994) 933-940
21. Wilmink A.B., Welch A.A., Quick C.R., Burns P.J., Hubbard C.S., Bradbury A.W., et al. Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg 39 (2004) 513-516
22. Merchant A.T., Hu F.B., Spiegelman D., Willett W.C., Rimm E.B., and Ascherio A. The use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J Nutr 133 (2003) 2863-2867
23. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
24. Bønaa K.H., Njølstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
25. Merchant A.T., Hu F.B., Spiegelman D., Willett W.C., Rimm E.B., and Ascherio A. Dietary fiber reduces peripheral arterial disease risk in men. J Nutr 133 (2003) 3658-3663
26. King D.E., Egan B.M., and Geesey M.E. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92 (2003) 1335-1339
27. Calder P.C. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107 (2004) 1-11
28. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003) 477-485
29. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296 (2006) 1885-1899
30. Stark A.H., and Madar Z. Olive oil as a functional food: epidemiology and nutritional approaches. Nutr Rev 60 (2002) 170-176
31. Carrero J.J., Lopez-Huertas E., Salmeron L.M., Baro L., and Ros E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr 135 (2005) 1393-1399